Rockwell Medical, Inc. (Rockwell) is a biopharmaceutical company targeting end-stage renal disease (ESRD) and chronic kidney disease (CKD) with products and services for the treatment of iron deficiency, secondary hyperparathyroidism and hemodialysis. The Company operates through the hemodialysis market segment, which involves the manufacture, sale and distribution of hemodialysis products to hemodialysis clinics, including pharmaceutical, dialysis concentrates, dialysis kits and other ancillary products used in the dialysis process. The Company's drug products include Triferic (ferric pyrophosphate citrate) and Calcitriol (Active Vitamin D) Injection. Triferic is an iron compound that is delivered to hemodialysis patients through dialysate, replacing the iron loss that occurs during their dialysis treatment. Calcitriol (active vitamin D) injection is indicated for treatment of secondary hyperparathyroidism in dialysis patients.
Industry, Sector and Symbol:
- Sector: Medical
- Industry: Specialty & Advanced Pharmaceuticals
- Sub-Industry: Health Care Equipment
- Symbol: NASDAQ:RMTI
- CUSIP: 77437410
- Web: www.rockwellmed.com
Capitalization:- Market Cap: $381.84 million
- Outstanding Shares: 51,740,000
Average Prices:- 50 Day Moving Avg: $6.47
- 200 Day Moving Avg: $7.00
- 52 Week Range: $3.55 - $8.98
P/E:- Trailing P/E Ratio: N/A
- Foreward P/E Ratio: -26.36
- P/E Growth: -0.78
Sales & Book Value:- Annual Revenue: $54.04 million
- Price / Sales: 7.07
- Book Value: $0.85 per share
- Price / Book: 8.68
Profitability:- EBIDTA: ($21,070,000.00)
- Net Margins: -39.68%
- Return on Equity: -42.22%
- Return on Assets: -27.15%
Debt:- Current Ratio: 8.33%
- Quick Ratio: 6.53%
Misc:- Average Volume: 155,992 shs.
- Beta: 2.1
- Short Ratio: 68.19
Frequently Asked Questions for Rockwell Medical (NASDAQ:RMTI)
What is Rockwell Medical's stock symbol?
Rockwell Medical trades on the NASDAQ under the ticker symbol "RMTI."
How were Rockwell Medical's earnings last quarter?
Rockwell Medical, Inc. (NASDAQ:RMTI) issued its earnings results on Wednesday, August, 9th. The company reported ($0.14) EPS for the quarter, missing the consensus estimate of ($0.10) by $0.04. The company had revenue of $13.24 million for the quarter, compared to analysts' expectations of $13.05 million. Rockwell Medical had a negative return on equity of 42.22% and a negative net margin of 39.68%. Rockwell Medical's revenue for the quarter was down 1.6% on a year-over-year basis. During the same quarter in the previous year, the firm posted ($0.11) earnings per share. View Rockwell Medical's Earnings History.
When will Rockwell Medical make its next earnings announcement?
Where is Rockwell Medical's stock going? Where will Rockwell Medical's stock price be in 2017?
3 analysts have issued 12 month price targets for Rockwell Medical's stock. Their forecasts range from $5.00 to $12.00. On average, they expect Rockwell Medical's share price to reach $9.33 in the next year. View Analyst Ratings for Rockwell Medical.
Who are some of Rockwell Medical's key competitors?
Some companies that are related to Rockwell Medical include Audentes Therapeutics (BOLD), AtriCure (ATRC), U.S. Physical Therapy (USPH), TG Therapeutics (TGTX), Revance Therapeutics (RVNC), Spectrum Pharmaceuticals (SPPI), Alder BioPharmaceuticals (ALDR), CryoLife (CRY), LeMaitre Vascular (LMAT), Civitas Solutions (CIVI), G1 THERAPEUTICS (GTHX), AnaptysBio (ANAB), Paratek Pharmaceuticals (PRTK), Aclaris Therapeutics (ACRS), Ignyta (RXDX), Seres Therapeutics (MCRB), Achaogen (AKAO) and Natera (NTRA).
Who are Rockwell Medical's key executives?
Rockwell Medical's management team includes the folowing people:
- Robert L. Chioini, Chairman of the Board, President, Chief Executive Officer
- Thomas E. Klema CPA, MBA, Chief Financial Officer, Vice President, Treasurer, Secretary
- Ajay Gupta M.D., Chief Scientific Officer
- Raymond D. Pratt M.D., Chief Medical Officer
- David Domzalski, Director
- Robin L. Smith M.D., Director
- Patrick J. Bagley, Independent Director
- Ronald D. Boyd, Independent Director
Who owns Rockwell Medical stock?
Rockwell Medical's stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include
RICHMOND BROTHERS, INC.
(10.80%), Vanguard Group Inc. (4.00%), State Street Corp (1.75%), Northern Trust Corp (1.19%), Perkins Capital Management Inc. (0.85%) and BKS Advisors LLC (0.46%). Company insiders that own Rockwell Medical stock include David S Richmond, Kenneth L Holt and Ronald D Boyd. View Institutional Ownership Trends for Rockwell Medical.
Who sold Rockwell Medical stock? Who is selling Rockwell Medical stock?
Rockwell Medical's stock was sold by a variety of institutional investors in the last quarter, including Perkins Capital Management Inc., Stifel Financial Corp, California State Teachers Retirement System, Rhumbline Advisers, Oppenheimer & Co. Inc., Benchmark Capital Advisors, The Manufacturers Life Insurance Company and Bank of New York Mellon Corp. View Insider Buying and Selling for Rockwell Medical.
Who bought Rockwell Medical stock? Who is buying Rockwell Medical stock?
Rockwell Medical's stock was acquired by a variety of institutional investors in the last quarter, including Vanguard Group Inc., State Street Corp, GSA Capital Partners LLP, Northern Trust Corp, National Asset Management Inc., Private Advisor Group LLC, PNC Financial Services Group Inc. and Wells Fargo & Company MN. View Insider Buying and Selling for Rockwell Medical.
How do I buy Rockwell Medical stock?
Shares of Rockwell Medical can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Rockwell Medical's stock price today?
One share of Rockwell Medical stock can currently be purchased for approximately $7.38.
MarketBeat Community Rating for Rockwell Medical (NASDAQ RMTI)MarketBeat's community ratings are surveys of what our community members think about Rockwell Medical and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Consensus Ratings for Rockwell Medical (NASDAQ:RMTI) (How are Consensus Ratings Calculated?) MarketBeat calculates consensus ratings using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings. Each stock's consensus rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
| Ratings Breakdown: | 1 Sell Rating, 1 Buy Rating, 1 Strong Buy Rating |
| Consensus Rating: | Buy (Score: 2.67) |
| Consensus Price Target: | $9.33 (26.47% upside) |
Analysts' Ratings History for Rockwell Medical (NASDAQ:RMTI)
Show:
| Date | Firm | Action | Rating | Price Target | Impact on Share Price | Details |
|---|
| 8/14/2017 | Ifs Securities | Initiated Coverage | Strong-Buy | $11.00 | Medium |  |
| 11/9/2016 | BTIG Research | Reiterated Rating | Buy | $12.00 | N/A | |
| 11/8/2016 | Bank of America Corporation | Downgrade | Neutral -> Underperform | $9.00 -> $5.00 | N/A | |
| 4/6/2016 | Morgan Stanley | Reiterated Rating | Sell | | N/A | |
| 3/1/2016 | Craig Hallum | Downgrade | Buy -> Hold | $7.00 | N/A | |
| 3/1/2016 | Stifel Nicolaus | Downgrade | Buy -> Hold | | N/A | |
| 11/12/2015 | Oppenheimer Holdings, Inc. | Reiterated Rating | Outperform | $26.00 | N/A | |
| 11/11/2015 | Brean Capital | Reiterated Rating | Sell | $4.00 | N/A | |
(Data available from 9/22/2015 forward)
Earnings History for Rockwell Medical (NASDAQ:RMTI)Earnings History by Quarter for Rockwell Medical (NASDAQ RMTI)| Date | Quarter | Consensus Estimate | Actual EPS | Revenue Estimate | Actual Revenue | Release Link | Conference Call | Details |
|---|
| 11/6/2017 | | ($0.10) | | | | | N/A | |
| 8/9/2017 | Q2 2017 | ($0.10) | ($0.14) | $13.05 million | $13.24 million | View | Listen | |
| 5/9/2017 | Q1 2017 | ($0.09) | ($0.09) | $12.66 million | $14.60 million | View | Listen | |
| 3/15/2017 | Q4 2016 | ($0.09) | ($0.10) | $15.45 million | $13.39 million | View | N/A | |
| 11/7/2016 | Q3 | ($0.10) | ($0.09) | $15.40 million | $12.81 million | View | Listen | |
| 8/8/2016 | Q2 | ($0.10) | ($0.11) | $13.86 million | $12.50 million | View | N/A | |
| 5/10/2016 | Q1 | ($0.08) | ($0.10) | $15.25 million | $13.63 million | View | Listen | |
| 2/29/2016 | Q4 | $0.02 | ($0.12) | $19.98 million | $14.10 million | View | Listen | |
| 11/9/2015 | Q315 | ($0.02) | ($0.05) | $14.93 million | $14.40 million | View | Listen | |
| 8/4/2015 | Q215 | ($0.10) | ($0.05) | $11.84 million | $12.96 million | View | Listen | |
| 5/7/2015 | Q414 | ($0.10) | ($0.07) | $13.20 million | $13.90 million | View | N/A | |
| 2/26/2015 | Q4 | ($0.10) | ($0.14) | $13.51 million | $14.40 million | View | N/A | |
| 11/10/2014 | Q314 | ($0.10) | ($0.10) | $13.40 million | $13.70 million | View | N/A | |
| 7/31/2014 | Q2 | ($0.13) | ($0.08) | $13.45 million | $13.00 million | View | N/A | |
| 5/12/2014 | Q1 | ($0.14) | ($0.20) | $14.22 million | $13.00 million | View | N/A | |
| 2/26/2014 | | ($0.28) | ($0.21) | | | View | N/A | |
| 11/8/2012 | Q312 | ($0.50) | ($0.86) | $12.57 million | $12.70 million | View | N/A | |
(Data available from 1/1/2011 forward)
Earnings Estimates for Rockwell Medical (NASDAQ:RMTI)| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|
| Q2 2017 | 1 | ($0.10) | ($0.10) | ($0.10) |
| Q3 2017 | 1 | ($0.10) | ($0.10) | ($0.10) |
| Q4 2017 | 1 | ($0.10) | ($0.10) | ($0.10) |
(Data provided by Zacks Investment Research)
Dividend History for Rockwell Medical (NASDAQ:RMTI)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading and Institutional Ownership History for Rockwell Medical (NASDAQ:RMTI)Insider Ownership Percentage: 15.90%
Institutional Ownership Percentage: 21.36%
Insider Trades by Quarter for Rockwell Medical (NASDAQ:RMTI)| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Details |
|---|
| 3/22/2017 | David S Richmond | Insider | Buy | 37,210 | $5.84 | $217,306.40 | |
| 3/16/2017 | Kenneth L Holt | Director | Sell | 6,000 | $5.98 | $35,880.00 | |
| 11/11/2016 | Kenneth L Holt | Director | Sell | 19,725 | $5.16 | $101,781.00 | |
| 11/1/2016 | Kenneth L Holt | Director | Sell | 1,400 | $5.92 | $8,288.00 | |
| 10/21/2016 | Kenneth L Holt | Director | Sell | 2,533 | $6.04 | $15,299.32 | |
| 9/19/2016 | Kenneth L Holt | Director | Sell | 8,075 | $6.81 | $54,990.75 | |
| 8/25/2016 | Kenneth L Holt | Director | Sell | 9,520 | $6.37 | $60,642.40 | |
| 8/16/2016 | Kenneth L Holt | Director | Sell | 3,692 | $7.31 | $26,988.52 | |
| 12/4/2015 | Ronald D. Boyd | Director | Sell | 12,500 | $10.58 | $132,250.00 | |
| 8/14/2015 | Robert L Chioini | CEO | Buy | 4,910 | $11.96 | $58,723.60 | |
| 8/13/2015 | Raymond Dennis Pratt | VP | Buy | 5,000 | $11.54 | $57,700.00 | |
| 8/13/2015 | Robert L Chioini | CEO | Buy | 5,090 | $11.51 | $58,585.90 | |
| 8/27/2012 | David A Hagelstein | Major Shareholder | Buy | 7,000 | $8.10 | $56,700.00 | |
(Data available from 1/1/2013 forward)
Headline Trends for Rockwell Medical (NASDAQ:RMTI)
Latest Headlines for Rockwell Medical (NASDAQ:RMTI)
| Source: |
|
| Date | Headline |
|---|
 | Rockwell Medical, Inc. breached its 50 day moving average in a Bullish Manner : RMTI-US : September 21, 2017
finance.yahoo.com - September 22 at 4:56 PM |
| Rockwell Medical, Inc. :RMTI-US: Earnings Analysis: Q2, 2017 By the Numbers : September 21, 2017
finance.yahoo.com - September 22 at 4:55 PM |
| ETFs with exposure to Rockwell Medical, Inc. : September 22, 2017
finance.yahoo.com - September 22 at 4:55 PM |
 | Financial Survey: Rockwell Medical (RMTI) and Its Peers
www.americanbankingnews.com - September 19 at 12:36 PM |
| Rockwell Medical (RMTI) versus Its Rivals Head-To-Head Review
www.americanbankingnews.com - September 18 at 4:30 PM |
 | Rockwell Medical Updates Progress on Calcitriol Commercial Launch - GlobeNewswire (press release)
globenewswire.com - September 13 at 3:49 PM |
| Head-To-Head Contrast: AbbVie (ABBV) versus Rockwell Medical (RMTI)
www.americanbankingnews.com - September 13 at 10:16 AM |
| Analyzing Rockwell Medical (RMTI) & its Rivals
www.americanbankingnews.com - September 10 at 8:38 AM |
 | Rockwell Medical Technologies (RMTI) Names John Cooper to Board
www.streetinsider.com - September 9 at 8:00 AM |
 | Richmond Brothers Comments on Appointment of John G. Cooper to Rockwell Medical, Inc. Board - Business Wire (press release)
www.businesswire.com - September 9 at 8:00 AM |
| Richmond Brothers Comments on Appointment of John G. Cooper to Rockwell Medical, Inc. Board
finance.yahoo.com - September 9 at 8:00 AM |
| Richmond Brothers Comments on Appointment of John G. Cooper to Rockwell Medical, Inc. Board
finance.yahoo.com - September 9 at 8:00 AM |
| Rockwell Medical Appoints John G. Cooper to Board of Directors - GlobeNewswire (press release)
globenewswire.com - September 8 at 7:45 AM |
| Rockwell Medical Appoints John G. Cooper to Board of Directors
finance.yahoo.com - September 8 at 7:45 AM |
| Rockwell Medical, Inc. (RMTI) Receives Consensus Rating of "Hold" from Analysts
www.americanbankingnews.com - September 8 at 2:44 AM |
| Macrocure (MCUR) versus Rockwell Medical (RMTI) Head-To-Head Comparison
www.americanbankingnews.com - September 6 at 10:49 AM |
| Richmond Brothers and Mark H. Ravich Releases Statement on Rockwell Medical, Inc. (RMTI)
www.streetinsider.com - September 1 at 8:07 AM |
| Head to Head Comparison: Rockwell Medical (RMTI) & Aimmune Therapeutics (AIMT)
www.americanbankingnews.com - August 31 at 12:30 PM |
| Rockwell Medical Technologies (RMTI) Responds to Richmond Group - StreetInsider.com
www.streetinsider.com - August 31 at 9:30 AM |
| Richmond Brothers and Mark H. Ravich Releases Statement on Rockwell Medical, Inc. (RMTI) - StreetInsider.com
www.streetinsider.com - August 31 at 9:29 AM |
| Richmond Brothers and Mark H. Ravich Issue Statement on Rockwell Medical, Inc. - Business Wire (press release)
www.businesswire.com - August 30 at 8:38 AM |
| Rockwell Medical Responds to Richmond Group Nasdaq:RMTI - GlobeNewswire (press release)
globenewswire.com - August 30 at 8:38 AM |
| Rockwell Medical Responds to Richmond Group
finance.yahoo.com - August 30 at 8:38 AM |
| Richmond Brothers Issues Public Letter to Incumbent Directors of Rockwell Medical, Inc.
finance.yahoo.com - August 30 at 8:38 AM |
| Richmond Brothers and Mark H. Ravich Issue Statement on Rockwell Medical, Inc.
finance.yahoo.com - August 30 at 8:38 AM |
 | Top shareholder in Rockwell Medical seeks ouster of CEO Chioini
seekingalpha.com - August 29 at 10:30 AM |
| Rockwell Medical, Inc. (RMTI) Upgraded by BidaskClub to Hold
www.americanbankingnews.com - August 28 at 6:50 PM |
| Critical Review: Supernus Pharmaceuticals (SUPN) & Rockwell Medical (RMTI)
www.americanbankingnews.com - August 22 at 8:30 AM |
| Rockwell Medical, Inc. (RMTI) Cut to Sell at Zacks Investment Research
www.americanbankingnews.com - August 15 at 11:48 AM |
| Rockwell Medical, Inc. (NASDAQ:RMTI) Receives Consensus Rating of "Hold" from Brokerages
www.americanbankingnews.com - August 14 at 1:08 PM |
| Rockwell Medical, Inc. (NASDAQ:RMTI) Research Coverage Started at Ifs Securities
www.americanbankingnews.com - August 14 at 12:28 PM |
| Rockwell Medical, Inc. (RMTI) Releases Earnings Results, Misses Estimates By $0.04 EPS
www.americanbankingnews.com - August 11 at 8:55 PM |
| Rockwell Medical's (RMTI) CEO Robert Chioini on Q2 2017 Results - Earnings Call Transcript - Seeking Alpha
seekingalpha.com - August 10 at 7:28 AM |
| Rockwell Medical Reports Second Quarter Results
finance.yahoo.com - August 10 at 7:28 AM |
| Edited Transcript of RMTI earnings conference call or presentation 9-Aug-17 8:30pm GMT
finance.yahoo.com - August 10 at 7:28 AM |
| Rockwell Medical reports 2Q loss
finance.yahoo.com - August 10 at 7:28 AM |
| Rockwell Medical Inc (NASDAQ:RMTI) Stock Rating Lowered by BidaskClub
www.americanbankingnews.com - August 5 at 5:30 PM |
| Contrasting Mallinckrodt PLC (MNK) & Rockwell Medical (NASDAQ:RMTI)
www.americanbankingnews.com - August 5 at 7:14 AM |
| Rockwell Medical Schedules Second Quarter 2017 Earnings Call
finance.yahoo.com - August 5 at 6:41 AM |
| Rockwell Medical, Inc. – Value Analysis (NASDAQ:RMTI) : August 1, 2017
finance.yahoo.com - August 2 at 7:15 AM |
| Head to Head Contrast: Rockwell Medical (RMTI) & DARA Biosciences (DARA)
www.americanbankingnews.com - July 31 at 10:30 AM |
| BidaskClub Lowers Rockwell Medical, Inc. (NASDAQ:RMTI) to Sell
www.americanbankingnews.com - July 29 at 12:59 PM |
| Rockwell Medical, Inc. breached its 50 day moving average in a Bearish Manner : RMTI-US : July 18, 2017
finance.yahoo.com - July 19 at 7:20 AM |
| Zacks Investment Research Upgrades Rockwell Medical, Inc. (RMTI) to Hold
www.americanbankingnews.com - July 12 at 1:02 PM |
| Rockwell Medical Announces Triferic® Presentation at Annual Conference on Nephrology & Urology July 6-7th, 2017 ... - GlobeNewswire (press release)
globenewswire.com - June 29 at 6:37 AM |
| Rockwell Medical Announces Triferic® Presentation at Annual Conference on Nephrology & Urology July 6-7th, 2017 ... - GlobeNewswire (press release)
globenewswire.com - June 29 at 6:37 AM |
| Rockwell Medical Announces Triferic® Presentation at Annual Conference on Nephrology & Urology July 6-7th, 2017, Kuala Lumpur, Malaysia
finance.yahoo.com - June 28 at 8:39 AM |
| Head-To-Head Contrast: Rockwell Medical (RMTI) & GlaxoSmithKline PLC (GSK)
www.americanbankingnews.com - June 18 at 4:10 PM |
| ETFs with exposure to Rockwell Medical, Inc. : June 15, 2017
finance.yahoo.com - June 16 at 9:26 AM |
| Rockwell Medical (RMTI) & Johnson & Johnson (JNJ) Financial Review
www.americanbankingnews.com - June 10 at 10:10 AM |
Rockwell Medical (RMTI) Chart for Friday, September, 22, 2017
